Farmers know better than anyone that agriculture never stands still. Every growing season brings new challenges, whether it’s ...
Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone for gene editing.
Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.
The CEO of Caszyme, a biotech company in Vilnius, Lithuania, presented details of Cas12l, a novel compact Cas nuclease with a ...
You’re reading Book Currents, a weekly column in which notable figures share what they’re reading. Sign up for the Goings On newsletter to receive their selections, and other cultural recommendations, ...
Researchers used adenine base editing in mice to correct a mutation that causes Dravet syndrome. The edit reduced seizures, ...
Colossal Biosciences Revives Bluebuck via Gene Editing CIA-backed de-extinction projects spark ethical debates, Jurassic Park ...
Researchers breakthrough gene silencing in chickens, enabling disease-resistant poultry. Learn how this genetic engineering advance brings commercial gene-edited flocks closer to reality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results